Amblyotech Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
3
- Latest Deal Type
-
M&A
Amblyotech General Information
Description
Developer of medical modalities platform designed to offer novel medical treatments for treating amblyopia and other ocular disorders. The company's platform uses active gaming and passive video technology with 3-D glasses, training the eyes to work together to view an image in full, enabling clients to access revolutionary treatment for ocular disorders.
Contact Information
Website
www.amblyotech.comCorporate Office
- 77 East Missouri Avenue
- Unit 67
- Phoenix, AZ 85012
- United States
Corporate Office
- 77 East Missouri Avenue
- Unit 67
- Phoenix, AZ 85012
- United States
Amblyotech Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Merger/Acquisition | 01-Apr-2020 | Completed | Generating Revenue | |||
3. Later Stage VC | 24-Jan-2020 | Completed | Generating Revenue | |||
2. Later Stage VC | 24-Jul-2019 | $150K | Completed | Generating Revenue | ||
1. Accelerator/Incubator | 01-May-2016 | $150K | $150K | Completed | Generating Revenue |
Amblyotech Patents
Amblyotech Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230149249-A1 | Method of improving stereoacuity using an interval-based protocol | Pending | 07-Feb-2020 | ||
EP-4099972-A1 | Method of improving stereoacuity using an interval-based protocol | Inactive | 07-Feb-2020 | ||
AU-2018373510-A1 | Method and apparatus for treating diplopia and convergence insufficiency disorder | Inactive | 24-Nov-2017 | ||
US-20190159956-A1 | Method and apparatus for treating diplopia and convergence insufficiency disorder | Inactive | 24-Nov-2017 | ||
US-20200306124-A1 | Method and apparatus for treating diplopia and convergence insufficiency disorder | Inactive | 24-Nov-2017 | A61B3/08 |
Amblyotech Signals
Amblyotech Former Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Jumpstart Foundry | Venture Capital | Minority | ||
Jumpstart Health Investors | VC-Backed Company | Minority | ||
Novartis Venture Fund | Corporate Venture Capital | Minority |
Amblyotech FAQs
-
When was Amblyotech founded?
Amblyotech was founded in 2013.
-
Where is Amblyotech headquartered?
Amblyotech is headquartered in Phoenix, AZ.
-
What is the size of Amblyotech?
Amblyotech has 3 total employees.
-
What industry is Amblyotech in?
Amblyotech’s primary industry is Other Healthcare Technology Systems.
-
Is Amblyotech a private or public company?
Amblyotech is a Private company.
-
What is Amblyotech’s current revenue?
The current revenue for Amblyotech is
. -
How much funding has Amblyotech raised over time?
Amblyotech has raised $885K.
-
Who are Amblyotech’s investors?
Jumpstart Foundry, Jumpstart Health Investors, and Novartis Venture Fund have invested in Amblyotech.
-
When was Amblyotech acquired?
Amblyotech was acquired on 01-Apr-2020.
-
Who acquired Amblyotech?
Amblyotech was acquired by Novartis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »